1. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25(34):7709-17. [
DOI:10.1523/JNEUROSCI.2177-05.2005] [
PMID] [
]
2. Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014;10(6):844-52. [
DOI:10.1016/j.jalz.2014.01.001] [
PMID] [
]
3. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734-46. [
DOI:10.1016/S1474-4422(07)70178-3] [
PMID]
4. Gauthier S, Loft H, Cummings J. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry. 2008;23(5):537-45. [
DOI:10.1002/gps.1949] [
PMID]
5. Goedert M, Spillantini MG. A century of Alzheimer's disease. Science. 2006;314(5800):777-81. [
DOI:10.1126/science.1132814] [
PMID]
6. Chan HH, Leong YQ, Voon SM, Pan ML, Leong CO, Lim CL, Koh RY. Effects of Amyloid Precursor Protein Overexpression on NF-κB, Rho-GTPase and Pro-Apoptosis Bcl-2 Pathways in Neuronal Cells. Rep Biochem Mol Biol. 2021;9(4):417-425. [
DOI:10.52547/rbmb.9.4.417] [
PMID] [
]
7. Biglari S, Kamali K, Banihashemi S, Faal Sezavari A, Aghajanpour-Mir SM, Behjati F. Investigation of Aneusomy of Chromosome 21 in the Micronuclei of 13 Patients with Early Onset Alzheimer's Disease Using Fluorescence in Situ Hybridization: A Pilot Study. Rep Biochem Mol Biol. 2020;8(4):446-453.
8. Raux G, Guyant-Maréchal L, Martin C, Bou J, Penet C, Brice A, et al. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J Med Genet. 2005;42(10):793-5. [
DOI:10.1136/jmg.2005.033456] [
PMID] [
]
9. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerrière A, Vital A, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet. 2006;38(1):24-6. [
DOI:10.1038/ng1718] [
PMID]
10. Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry. 2007;68(4):613-8. [
DOI:10.4088/JCP.v68n0419] [
PMID]
11. Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell. 2013;153(3):707-20. [
DOI:10.1016/j.cell.2013.03.030] [
PMID] [
]
12. Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging. 2006;27(10):1372-84. [
DOI:10.1016/j.neurobiolaging.2005.09.012] [
PMID]
13. Rupsingh R, Borrie M, Smith M, Wells JL, Bartha R. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol Aging. 2011;32(5):802-10. [
DOI:10.1016/j.neurobiolaging.2009.05.002] [
PMID]
14. Vezzani A, Sperk G. Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy? Neuropeptides. 2004;38(4):245-52. [
DOI:10.1016/j.npep.2004.05.004] [
PMID]
15. Xapelli S, Silva AP, Ferreira R, Malva JO. Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures. Peptides. 2007;28(2):288-94. [
DOI:10.1016/j.peptides.2006.09.031] [
PMID]
16. Ammar DA, Eadie DM, Wong DJ, Ma YY, Kolakowski LF Jr, Yang-Feng TL, Thompson DA. Characterization of the human type 2 neuropeptide Y receptor gene (NPY2R) and localization to the chromosome 4q region containing the type 1 neuropeptide Y receptor gene. Genomics. 1996;38(3):392-8. [
DOI:10.1006/geno.1996.0642] [
PMID]
17. Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, et al. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem. 1995;270(39):22661-4. [
DOI:10.1074/jbc.270.39.22661] [
PMID]
18. Broberger C, Landry M, Wong H, Walsh JN, Hökfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology. 1997;66(6):393-408. [
DOI:10.1159/000127265] [
PMID]
19. Gerald C, Walker MW, Vaysse PJ, He C, Branchek TA, Weinshank RL. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J Biol Chem. 1995;270(45):26758-61. [
DOI:10.1074/jbc.270.45.26758] [
PMID]
20. Morales-Medina JC, Dumont Y, Quirion R. A possible role of neuropeptide Y in depression and stress. Brain Res. 2010;1314:194-205. [
DOI:10.1016/j.brainres.2009.09.077] [
PMID]
21. Rose JB, Crews L, Rockenstein E, Adame A, Mante M, Hersh LB, et al. Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease. J Neurosci. 2009;29(4):1115-25. [
DOI:10.1523/JNEUROSCI.4220-08.2009] [
PMID] [
]
22. Kloster E, Saft C, Akkad DA, Epplen JT, Arning L. Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R. J Mol Med (Berl). 2014;92(2):177-84. [
DOI:10.1007/s00109-013-1092-3] [
PMID]
23. Silva AP, Pinheiro PS, Carvalho AP, Carvalho CM, Jakobsen B, Zimmer J, Malva JO. Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J. 2003;17(9):1118-20. [
DOI:10.1096/fj.02-0885fje] [
PMID]
24. Arning L, Stock AK, Kloster E, Epplen JT, Beste C. NPY2-receptor variation modulates iconic memory processes. Eur Neuropsychopharmacol. 2014;24(8):1298-302. [
DOI:10.1016/j.euroneuro.2014.03.003] [
PMID]
25. Lu ZL, Neuse J, Madigan S, Dosher BA. Fast decay of iconic memory in observers with mild cognitive impairments. Proc Natl Acad Sci U S A. 2005;102(5):1797-802. [
DOI:10.1073/pnas.0408402102] [
PMID] [
]
26. Penner J, Rupsingh R, Smith M, Wells JL, Borrie MJ, Bartha R. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(1):104-10. [
DOI:10.1016/j.pnpbp.2009.10.007] [
PMID]